zanubrutinib

1633350-06-7

2-(4-phenoxyphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide

7-(1-Acryloyl-4-piperidinyl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-carboxamid

7-(1-Acryloyl-4-piperidinyl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide

7-(1-Acryloyl-4-pipéridinyl)-2-(4-phénoxyphényl)-4,5,6,7-tétrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide

Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-

zanubrutinib

(��)-Zanubrutinib

(R)-Zanubrutinib

(±)-Zanubrutinib

1691249-44-1

1691249-45-2

AG9MHG098Z

Brukinsa

BTK_HUMAN

EGFR_HUMAN

Epidermal growth factor receptor

MFCD30738015

MFCD31567462

TEC_HUMAN

Tyrosine-protein kinase BTK

Tyrosine-protein kinase Tec

Zanubrutinib (BGB-3111)